Edition:
United Kingdom

Wuxi Biologics Cayman Inc (2269.HK)

2269.HK on Hong Kong Stock

63.95HKD
16 Oct 2018
Change (% chg)

HK$-1.05 (-1.62%)
Prev Close
HK$65.00
Open
HK$65.70
Day's High
HK$65.85
Day's Low
HK$63.00
Volume
5,288,520
Avg. Vol
5,332,656
52-wk High
HK$98.50
52-wk Low
HK$38.75

Latest Key Developments (Source: Significant Developments)

Wuxi Biologics Cayman Inc Posts HY Profit Attributabe RMB249.6 Mln
Monday, 20 Aug 2018 

Aug 20 (Reuters) - Wuxi Biologics Cayman Inc <2269.HK>::HY PROFIT ATTRIBUTABE RMB249.6 MILLION VERSUS RMB92.2 MILLION.HY REVENUE RMB1.05 BILLION VERSUS RMB654 MILLION.  Full Article

WuXi Biologics Cayman Sees An Increase In HY Net Profit
Sunday, 22 Jul 2018 

July 23 (Reuters) - WuXi Biologics Cayman Inc <2269.HK>::EXPECTED THAT NET PROFIT OF GROUP FOR SIX MONTHS ENDED JUNE 30, 2018 WILL BE MORE THAN 250 PCT.EXPECTED RESULT DUE TO GROWTH IN REVENUE DRIVEN BY GROUP'S "FOLLOW-THE-MOLECULE" STRATEGY .  Full Article

Wuxi Biologics Cayman Says Co Through Units Enters Joint Venture Agreement With Hile
Wednesday, 18 Jul 2018 

July 18 (Reuters) - Wuxi Biologics Cayman Inc <2269.HK>::CO THROUGH UNITS ENTERED JOINT VENTURE AGREEMENT WITH HILE.COMPANY AND HILE WILL CONTRIBUTE IN CASH RMB350 MILLION AND RMB150 MLNTO JV, RESPECTIVELY.JV TO ENGAGE IN HUMAN VACCINE CDMO BUSINESS AND PROVISION OF END-TO-END INTEGRATED SERVICE.  Full Article

Wuxi Biologics Cayman Announces Placing Of Existing Shares By Controlling Shareholder
Tuesday, 19 Jun 2018 

June 20 (Reuters) - Wuxi Biologics Cayman Inc <2269.HK>::PLACING AGENT TO PLACE 50 MILLION EXISTING SHARES OF CO HELD BY BIOLOGICS HOLDINGS AT HK$79.2 EACH.  Full Article

Wuxi Biologics Cayman Plans To Establish New Biologics Centre In Shijiazhuang
Wednesday, 16 May 2018 

May 16 (Reuters) - Wuxi Biologics Cayman Inc <2269.HK>::PLANS TO ESTABLISH NEW BIOLOGICS CENTRE IN SHIJIAZHUANG, CHINA.  Full Article

Wuxi Biologics Cayman Expects‍ FY Net Profit To Be RMB321 Mln To RMB328 Mln
Sunday, 4 Mar 2018 

March 5 (Reuters) - Wuxi Biologics Cayman Inc <2269.HK>::‍NET PROFIT IS EXPECTED TO BE ABOUT RMB321 MILLION TO RMB328 MILLION​ FOR FY.EXPECTED RESULT DUE TO ‍EFFICIENCY ENHANCEMENT OF GROUP'S BUSINESS OPERATION​.  Full Article

Wuxi Biologics (Cayman) ‍Says To Place 126 Mln Shares
Thursday, 14 Dec 2017 

Dec 14 (Reuters) - Wuxi Biologics Cayman Inc <2269.HK>::‍CO TO PLACE 126 MILLION SHARES FOR PRICE OF HK$40.25 PER SHARE.  Full Article

UPDATE 3-China's Ascletis closes flat on debut in HK's first float under new biotech rules

* At least 10 more biotechs plan HK listings this year (Recasts; adds Ascletis' stock close)